Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children

Turkish Journal of Pediatrics

Volumn 50, Issue 3, 2008, Pages 228-234

  Tezer, Hasan ^a   Seçmeer, Gülten ^a   Kara, Ateş ^a   Ceyhan, Mehmet ^a   Cengiz, A Bülent ^a   Devrim, Ilker ^a   Us, Dürdal ^a   Yüce, Aysel ^a   Gürakan, Figen ^a   Yildirim, Inci ^a   Özen, Hasan ^a   Saltik Temizel, Inci Nur ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cholestasis; Cytomegalovirus; Ganciclovir; Hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; VITAMIN;

ARTICLE; BILE DUCT ATRESIA; CHOLESTATIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DEMOGRAPHY; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG INDICATION; FOLLOW UP; GENETIC DISORDER; HOSPITAL ADMISSION; HUMAN; IMMUNOCOMPETENCE; INBORN ERROR OF METABOLISM; INFANT; INFECTION; PATIENT ASSESSMENT; PATIENT CODING; PATIENT SELECTION; PRESCHOOL CHILD; RELAPSE; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SYMPTOM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VIRUS HEPATITIS; VOMITING;

ANTIVIRAL AGENTS; CHILD, PRESCHOOL; CHOLESTASIS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOCOMPETENCE; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 54749125837     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. EASL Jury. EASL international consensus conference on hepatitis B. J Hepatol 2003; 38: 533-540.
2. White FV, Dehner LP. Viral diseases of the liver in children: diagnostic and differential diagnostic considerations. Pediatr Dev Pathol 2004; 7: 552-567.
3. Jonas MM. Postnatal infections of the liver. Viral hepatitis. In: Walker WA (ed). Pediatric Gastrointestinal Disease. Boston: B.C. Decker; 2000: 939-964.
4. Whitley RJ. Congenital cytomegalovirus infection: epidemiology and treatment. Adv Exp Med Biol 2004; 549: 155-160.
5. Fischler B, Casswall TH, Malmborg P, Nemeth A. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr 2002; 34: 154-157.
6. Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 1997; 24: 52-56.
7. Zuppan CW, Bui HD, Grill BG. Diffuse hepatic fibrosis in congenital cytomegalovirus infection. J Pediatr Gastroenterol Nutr 1986; 5: 489-491.
8. McGavin JK, Goa KL. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 2001; 61: 1153-1183.
9. Nigro G, Taliani G, Krzysztopak A, et al. Multiple viral infections in HIV-infected children with chronically-evolving hepatitis. Arch Virol [Suppl] 1993; 8: 237-248.
10. Hadaya K, Kaiser L, Rubbia-Brandt L, Gervaix A, Diana A. Ganciclovir for severe cytomegalovirus primary infection in an immunocompetent child. Eur J Clin Microbiol Infect Dis 2004; 23: 218-220.
11. Rosenthal P. Neonatal hepatitis and congenital infections. In: Suchy F (ed). Liver Disease in Children (2nd ed). Philadelphia: Lippincott William Wilkins, 2001: 239-252.
12. Fischler B, Ehrnst A, Forsgren M, Orvell C, Nemeth A. The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1998; 27: 57-64.
13. Tarr PI, Haas JE, Christie DL. Biliary atresia, cytomegalovirus, age at referral. Pediatrics 1996; 97: 828-831.
14. Ho M. Cytomegalovirus: Biology and Infection (2nd ed). New York: Plenum Press; 1991.
15. Domiati-Saad R, Dawson DB, Margraf LR, Finegold MJ, Weinberg AG, Rogers BB. Cytomegalovirus and human herpesvirus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia. Pediatr Dev Pathol 2000; 3: 367-373.
16. Vancikova Z, Kucerova T, Pelikan L, Zikmundova L, Priglova M. Perinatal cytomegalovirus hepatitis: to treat or not to treat with ganciclovir. J Paediatr Child Health 2004; 40: 444-448.
17. Vancikova Z, Dvorak P. Cytomegalovirus infection in immunocompetent and immunocompromised individuals - a review. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1: 284-301.
18. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, Koszinowski UH. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus infection. J Exp Med 1994; 179: 1713-1717.
19. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326: 663-667.